Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartwig Huland

Showing results (41-50 of 368) with videos related to

Pageof 37
Sort By:
European Urology|August 12, 2008
Sequential use of the tyrosine kinase inhibitors sorafenib and sunitinib in metastatic renal cell carcinoma: a retrospective outcome analysisChristian Eichelberg, Roman Heuer, Felix K Chun, et al.
Urology|March 13, 2016
The Role of Pelvic Lymph Node Dissection During Radical Prostatectomy in Patients With Gleason 6 Intermediate-risk Prostate CancerPhilipp Mandel, Maximilian C Kriegmair, Valia Veleva, et al.
BJU International|August 18, 2005
Detection of human telomerase RNA in the tumour-surrounding mucosa of bladder carcinomas as a marker for premalignant transformationSven Leuenroth, Sabine Riethdorf, Andreas Erbersdobler, et al.
Urologic Oncology|February 1, 2020
The impact of very high initial PSA on oncological outcomes after radical prostatectomy for clinically localized prostate cancerDerya Tilki, Philipp Mandel, Pierre I Karakiewicz, et al.
Urologic Oncology|December 17, 2013
Does increasing life expectancy affect competing mortality after radical prostatectomy?Michael Froehner, Rainer Koch, Manfred P Wirth, et al.
Journal of Cancer Research and Clinical Oncology|September 27, 2003
Characterisation of biomolecular profiles in primary high-grade prostate cancer treated by radical prostatectomyHerbert Augustin, Peter G Hammerer, Markus Graefen, et al.
Proteomics|October 1, 2005
Stage-dependent increase of orosomucoid and zinc-alpha2-glycoprotein in urinary bladder cancerSter Irmak, Derya Tilki, Jochen Heukeshoven, et al.
The Journal of Urology|June 7, 2006
Prediction of postoperative sexual function after nerve sparing radical retropubic prostatectomyUwe H G Michl, Martin G Friedrich, Markus Graefen, et al.
Clinical Genitourinary Cancer|October 12, 2019
Advancing Age and the Odds of Upgrading and Upstaging at Radical Prostatectomy in Men with Gleason Score 6 Prostate CancerJonathan E Leeman, Ming-Hui Chen, Hartwig Huland, et al.
European Urology|May 10, 2002
Tumour grade, proliferation, apoptosis, microvessel density, p53, and bcl-2 in prostate cancers: differences between tumours located in the transition zone and in the peripheral zoneAndreas Erbersdobler, Henning Fritz, Silvia Schnöger, et al.
Pageof 37

Showing results (41-50 of 368) with videos related to

Sort By:
Pageof 37
European Urology|August 12, 2008
Sequential use of the tyrosine kinase inhibitors sorafenib and sunitinib in metastatic renal cell carcinoma: a retrospective outcome analysisChristian Eichelberg, Roman Heuer, Felix K Chun, et al.
Urology|March 13, 2016
The Role of Pelvic Lymph Node Dissection During Radical Prostatectomy in Patients With Gleason 6 Intermediate-risk Prostate CancerPhilipp Mandel, Maximilian C Kriegmair, Valia Veleva, et al.
BJU International|August 18, 2005
Detection of human telomerase RNA in the tumour-surrounding mucosa of bladder carcinomas as a marker for premalignant transformationSven Leuenroth, Sabine Riethdorf, Andreas Erbersdobler, et al.
Urologic Oncology|February 1, 2020
The impact of very high initial PSA on oncological outcomes after radical prostatectomy for clinically localized prostate cancerDerya Tilki, Philipp Mandel, Pierre I Karakiewicz, et al.
Urologic Oncology|December 17, 2013
Does increasing life expectancy affect competing mortality after radical prostatectomy?Michael Froehner, Rainer Koch, Manfred P Wirth, et al.
Journal of Cancer Research and Clinical Oncology|September 27, 2003
Characterisation of biomolecular profiles in primary high-grade prostate cancer treated by radical prostatectomyHerbert Augustin, Peter G Hammerer, Markus Graefen, et al.
Proteomics|October 1, 2005
Stage-dependent increase of orosomucoid and zinc-alpha2-glycoprotein in urinary bladder cancerSter Irmak, Derya Tilki, Jochen Heukeshoven, et al.
The Journal of Urology|June 7, 2006
Prediction of postoperative sexual function after nerve sparing radical retropubic prostatectomyUwe H G Michl, Martin G Friedrich, Markus Graefen, et al.
Clinical Genitourinary Cancer|October 12, 2019
Advancing Age and the Odds of Upgrading and Upstaging at Radical Prostatectomy in Men with Gleason Score 6 Prostate CancerJonathan E Leeman, Ming-Hui Chen, Hartwig Huland, et al.
European Urology|May 10, 2002
Tumour grade, proliferation, apoptosis, microvessel density, p53, and bcl-2 in prostate cancers: differences between tumours located in the transition zone and in the peripheral zoneAndreas Erbersdobler, Henning Fritz, Silvia Schnöger, et al.
Pageof 37